In the United States Court of Federal Claims
OFFICE OF SPECIAL MASTERS
No. 14-370V
Filed: July 3, 2015
* * * * * * * * * * * * * * * * UNPUBLISHED
DEBRA BUB, *
* Special Master Hamilton-Fieldman
Petitioner, *
* Joint Stipulation on Damages;
v. * Tetanus-Diptheria-acellular
* Pertussis (“Tdap”) Vaccine;
SECRETARY OF HEALTH * Allergic Reaction; Damage to
AND HUMAN SERVICES, * Immune System.
*
Respondent. *
* * * * * * * * * * * * * * * *
Clifford L. Shoemaker, Shoemaker, Gentry & Knickelbein, Vienna, VA, for Petitioner.
Claudia Barnes Gangi, United States Department of Justice, Washington, D.C., for Respondent.
DECISION 1
On April 30, 2014, Debra Bub (“Petitioner”) filed a petition pursuant to the National
Vaccine Injury Compensation Program. 2 42 U.S.C. §§ 300aa-1 to -34 (2006). Petitioner alleged
that a Tetanus-Diptheria-acellular Pertussis (“Tdap”) vaccination administered on August 25,
2013 caused her to develop an allergic reaction that damaged her immune system.
On July 2, 2015, the parties filed a stipulation in which they state that a decision should
be entered awarding compensation. Respondent denies that the Tdap vaccine caused Petitioner’s
alleged allergic reaction, immune-mediated condition, or other injury, or her current disabilities.
1
Because this decision contains a reasoned explanation for the undersigned’s action in this case,
the undersigned intends to post this ruling on the website of the United States Court of Federal
Claims, in accordance with the E-Government Act of 2002, Pub. L. No. 107-347, § 205, 116
Stat. 2899, 2913 (codified as amended at 44 U.S.C. § 3501 note (2006)). As provided by
Vaccine Rule 18(b), each party has 14 days within which to request redaction “of any
information furnished by that party: (1) that is a trade secret or commercial or financial in
substance and is privileged or confidential; or (2) that includes medical files or similar files, the
disclosure of which would constitute a clearly unwarranted invasion of privacy.” Vaccine Rule
18(b).
2
The National Vaccine Injury Compensation Program is set forth in Part 2 of the National
Childhood Vaccine Injury Act of 1986, Pub. L. No. 99-660, 100 Stat. 3755, codified as amended,
42 U.S.C. §§ 300aa-1 to -34 (2006) (Vaccine Act or the Act). All citations in this decision to
individual sections of the Vaccine Act are to 42 U.S.C.A. § 300aa.
1
Nevertheless, the parties agree to the joint stipulation, attached hereto as Appendix A. The
undersigned finds the stipulation reasonable and adopts it as the decision of the Court in
awarding damages, on the terms set forth therein.
The parties stipulate that Petitioner shall receive the following compensation:
A lump sum of $75,000.00 in the form of a check payable to Petitioner. This
amount represents compensation for all damages that would be available
under 42 U.S.C. § 300aa-15(a).
Stipulation ¶ 8.
The undersigned approves the requested amount for Petitioner’s compensation.
Accordingly, an award should be made consistent with the stipulation.
In the absence of a motion for review filed pursuant to RCFC Appendix B, the clerk of
the court SHALL ENTER JUDGMENT in accordance with the terms of the parties’
stipulation. 3
IT IS SO ORDERED.
s/ Lisa Hamilton-Fieldman
Lisa Hamilton-Fieldman
Special Master
3
Pursuant to Vaccine Rule 11(a), entry of judgment is expedited by the parties’ joint filing of
notice renouncing the right to seek review.
2
Case 1:14-vv-00370-UNJ Document 36 Filed 07/02/15 Page 1 of 5
Case 1:14-vv-00370-UNJ Document 36 Filed 07/02/15 Page 2 of 5
Case 1:14-vv-00370-UNJ Document 36 Filed 07/02/15 Page 3 of 5
Case 1:14-vv-00370-UNJ Document 36 Filed 07/02/15 Page 4 of 5
Case 1:14-vv-00370-UNJ Document 36 Filed 07/02/15 Page 5 of 5